The US FDA have made an announcement followed by issuing a summary report on findings of a third-party review of the agency’s pandemic response efforts, the PREPP which was undertaken from July to December 2020. Based on the summary report findings as well as current FDA priorities and responsibilities, the agency will initially focus on five PREPP-related efforts. The […]
US FDA has reissued one of its Emergency Use Authorizations (EUAs) covering imported respirators that have not been approved by the National Institute for Occupational Safety and Health (NIOSH). The “Umbrella EUA for Imported, Non-NIOSH-Approved Disposable Filtering Facepiece Respirators (FFRs)” continues to be valid, but the FDA is now restricting its use to previously authorized […]
ANVISA has issued new regulations about economic monitoring of certain device types in order to boost transparency and establish reference pricing for these products. The regulation, RDC 478/2021 (link in Portuguese), slated to take effect April 1, 2021 revokes economic monitoring and reporting processes previously established under RDC 185/2006, and initially reduces the number of medical device types for […]
Health Canada have released a notice on research use only Covid tests and clarified its stand. The “For Research Use Only” labeled devices shall be used only in the laboratories during the development phase or for pilot testing and cannot be used either for clinical trial or commercial testing or for sale. The In-vitro diagnostic […]
India’s Ministry of Health and Family Welfare has proposed recognizing American Standard Test Methods (ASTM) as acceptable tools for demonstrating conformance of medical devices to safety and conformance requirements and obtaining market access in the country. The notification would amend India’s Medical Device Rules, 2017 to allow medical device market applicants to use ASTM methods to demonstrate […]
Australia’s TGA is currently reforming the regulation of software-based medical devices, with an amendment that introduces significant regulatory carve-outs taking effect this week after being postponed due to the COVID-19 pandemic. In support of the changes found in the amendment, the TGA has published guidance on the regulation of clinical decision support software (CDSS) on its website. This guidance document has been […]
TGA has published the Therapeutic Goods (Excluded Goods) Amendment (Software-Based Products) Determination 2021, which will become effective on February 25, 2021. This amends the Therapeutic Goods (Excluded Goods) Determination 2018 to identify software-based devices, including software as a medical device (SaMD), that are excluded from the TGA’s medical device regulatory framework and should not be included in the […]
CFDA have announced two important medical devices regulatory, first about the classification changes, and the second regarding the submission of unique device identifier (UDI) data. Adjustments in classification catalog NMPA has partially revised the Medical Device Classification Catalog, as discussed in Announcement No. 147 of 2020 (link in Chinese). Considerable changes include down-classification of 15 device types […]
Stark Associates announced winning a strategic contract to support Research & Development for COVID-19 protective gear along with regulatory submissions for a Louisville, KY based, Medical Devices Manufacturing Company in partnership with University of Louisville (UofL), KY. The proposed project will see Stark supporting Research & Development for the nanotechnology based color changing biosensors in […]
From Stark Associates we would like to take this opportunity to wish everyone a very happy 4th of July!!! This holiday means so much to us because the freedom and liberty we enjoy is ultimately what makes entrepreneurism possible. We are blessed to live in a country that celebrates entrepreneurism and provides us with a […]